Filed by AcelRx Pharmaceuticals, Inc.

(Commission File No. 001-35068)

pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

 

Subject Company: Tetraphase Pharmaceutials, Inc.

(Commission File No. 001-35837